1250999-20-2 Usage
Uses
Used in Pharmaceutical Industry:
2-Bromo-5,6-dihydro-8H-imidazo[1,2-a]pyrazine-7-carboxylic acid tert-butyl ester is utilized as a key intermediate in the synthesis of various drug molecules. Its unique structure and functional groups make it a valuable building block for the development of new pharmaceuticals with diverse therapeutic applications.
Used in Organic Synthesis:
As a reagent in organic synthesis, 2-Bromo-5,6-dihydro-8H-imidazo[1,2-a]pyrazine-7-carboxylic acid tert-butyl ester is employed to facilitate the formation of complex organic molecules. Its bromide substituent and tert-butyl ester group can be strategically modified to achieve desired chemical transformations, making it a versatile component in the synthesis of a wide range of organic compounds.
Used in Antimicrobial Applications:
2-Bromo-5,6-dihydro-8H-imidazo[1,2-a]pyrazine-7-carboxylic acid tert-butyl ester has been studied for its antimicrobial properties, making it a potential candidate for the development of new antimicrobial agents. Its ability to inhibit the growth of various microorganisms could contribute to the fight against antibiotic-resistant bacteria and other infectious diseases.
Used in Antiparasitic Applications:
2-Bromo-5,6-dihydro-8H-imidazo[1,2-a]pyrazine-7-carboxylic acid tert-butyl ester has also demonstrated potential antiparasitic effects, which could be harnessed in the development of treatments for parasitic infections. Its ability to target and eliminate parasites could provide a new approach to combating diseases caused by various parasites.
Used in Antitumor Applications:
Research into the antitumor effects of 2-Bromo-5,6-dihydro-8H-imidazo[1,2-a]pyrazine-7-carboxylic acid tert-butyl ester has shown promise in its potential to inhibit tumor growth and progression. Its use as an antitumor agent could lead to the development of novel cancer therapies, offering new treatment options for patients with various types of cancer.
Check Digit Verification of cas no
The CAS Registry Mumber 1250999-20-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,0,9,9 and 9 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1250999-20:
(9*1)+(8*2)+(7*5)+(6*0)+(5*9)+(4*9)+(3*9)+(2*2)+(1*0)=172
172 % 10 = 2
So 1250999-20-2 is a valid CAS Registry Number.
1250999-20-2Relevant articles and documents
Substituted ring compound and its method and use thereof
-
Paragraph 0922; 0923; 0924; 0925, (2017/08/25)
The invention provides a substituted cyclic compound as well as a use method and application thereof. The compound is a compound as shown in a formula (I) or stereoisomers, stereomers, tautomers, nitric oxides, solvates, metabolites and pharmaceutically acceptable salts or prodrugs of the compound as shown in the formula (I). The invention further provides a medicament composition containing the compound. The compound and the medicament composition are capable of regulating the activity of protein kinase in a biological sample body and are used for protecting, treating or relieving proliferative diseases of patients. The formula (I) is as shown in the specification.
Three nitrogen antifungal compound, its pharmaceutical composition and its preparation and use
-
, (2016/10/20)
The present invention provides triazole compounds expressed by a general formula (I), and optical isomers or pharmaceutically acceptable salts thereof; and application of the compounds, and the optical isomers or pharmaceutically acceptable salts thereof
SUBSTITUTED CYCLIC COMPOUNDS AND METHODS OF USE
-
Paragraph 0312, (2014/06/24)
The present invention provides novel substituted alkynyl compounds, pharmaceutical acceptable salts and formulations thereof useful in modulating the protein tyrosine kinase activity, and in modulating cellular activities such as proliferation, differentiation, apoptosis, migration and invasion. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.
